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Purpose: To determine the feasibility of multiphasic dynamic CT 
including multiple arterial phases for evaluation of liver tissue 
perfusion characteristics using the maximum slope model in rabbits and 
in humans, compared with perfusion CT (PCT) as the standard of 
reference  
Materials and Methods: In an animal study, PCT was performed in 
six rabbits with VX2 tumors and in five rabbits without tumors. To 
determine the feasibility of multiphasic dynamic CT when used to 
obtain perfusion parameters, two data sets were selected from the PCT 
data set: 1) seven-phase images including five arterial phases; and 2) 
five-phase images with triple arterial phases including information 
regarding the peak aortic and splenic enhancement. In a human study, 
PCT was also performed in 23 patients with chronic liver diseases.  
Ten of these 23 patients were classified as the validation group in order 
to verify the results of the animal study, and the remaining 13 patients 
were classified as the evaluation group. Five–phase, dynamic CT 
including unenhanced, triple-arterial phases and the portal phase, were 
selected in order to obtain perfusion parameters of liver parenchyma 
using a maximum slope method. Those selected CT datasets and the 
whole PCT data sets were analyzed using dedicated perfusion software 
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(VPCT body; Siemens Healthcare) for estimating the perfusion 
parameters. Comparison between the perfusion parameters calculated 
from the multiphasic dynamic CT datasets and those of PCT was made 
using the intraclass correlation coefficient. 
Results: In the rabbit study, the perfusion parameters of both the liver 
parenchyma and the VX2 tumors obtained with either seven- or five-
phase image data sets did not differ significantly compared with those 
of PCT and they showed excellent agreement with those of PCT (ICCs 
> 0.60, p value < 0.05). In addition, all of the perfusion parameters of 
patient liver parenchyma obtained by five-phase images in the 23 
patients, did not differ significantly compared with those of PCT and 
they showed very high agreement with PCT (ICCs > 0.80, P-value < 
0.01) in both the validation and the evaluation groups. 
Conclusion: It was feasible to obtain perfusion parameters of the liver 
and tumors using multiphasic dynamic CT scans, and the perfusion 











Arterial liver perfusion 
Portal venous perfusion 
Hepatic perfusion index 
Multiphasic dynamic CT 
 













영문초록 ........................................................................................... i 
목차 ............................................................................................... iv 
List of Tables  .............................................................................. v 
List of Figures .............................................................................. vi 
Introduction  ................................................................................. 1 
Material and Methods ................................................................... 3 
Results ......................................................................................... 15 
Discussion ................................................................................... 18 
Tables .......................................................................................... 25 
Figures......................................................................................... 29 
References .................................................................................. 35 
국문초록 ........................................................................................ 40 
v 
 
LIST OF TABLES  
 
Table 1. Perfusion parameters determined by PCT and 
both seven- and five–phase, dynamic CT data sets  ........... 25 
 
Table 2. Intraclass correlation coefficients between the 
perfusion parameters of PCT and the perfusion 
parameters of both the seven- and five–phase, dynamic 
CT data sets ............................................................................. 26 
 
Table 3. Perfusion parameters determined by PCT and 
the multiphasic dynamic CT data set in the patient 
validation group ........................................................................ 27 
 
 Table 4. Perfusion parameters determined by PCT and 
by the five-phase dynamic CT data set in the patient 




LIST OF FIGURES 
 
Figure 1. PCT analysis ............................................................ 29 
 
Figure 2. Time-enhancement curves obtained by the 



















Alteration of hepatic blood flow is one of the remarkable 
pathophysiological changes in several important liver diseases 
including hepatic tumors and liver parenchymal disease such as 
cirrhosis [1]. With the recent technological development of MDCT and 
MR imaging, evaluation of hemodynamic change of the liver is 
possible using perfusion CT (PCT) or dynamic contrast-enhanced MRI, 
both of which are regarded as valuable tools for the evaluation of liver 
diseases including hepatic fibrosis and liver cirrhosis as well as the 
treatment response of liver malignancies. PCT of the liver, which was 
first described in 1991 [2], is one of the modalities which can acquire 
the liver perfusion parameters which reveal the hemodynamic changes 
in the liver; it has helped to expand the role of CT from a purely 
anatomic imaging tool to a combined morphologic-functional technique 
[3-7]. However, until now, PCT has been applied in clinical practice 
with only limited use, mainly due to concerns regarding the increased 
radiation dose and the poor imaging quality resulting from the use of 
low-tube voltage in order to decrease the radiation dose [1, 6, 8-10].  
Among the various perfusion values that can be obtained using 
PCT, arterial liver perfusion (ALP), portal venous perfusion (PVP), and 
the hepatic perfusion index (HPI) are considered to be important 
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parameters for showing the hemodynamic features of both malignant 
liver tumors and liver parenchymal disease. Regarding liver 
parenchymal disease, such as cirrhosis, progression of cirrhosis leads to 
decreased portal blood flow which is compensated for by an increase in 
arterial flow in order to improve liver oxygenation [1]. Therefore, liver 
cirrhosis results in an increase of HPI, due to an increase of ALP and 
decrease of PVP on PCT [1, 11-13]. For malignant liver tumors, the 
process of neoangiogenesis which results in an increase of ALP rather 
than of PVP, occurs for both hepatocellular carcinoma (HCC) and 
metastatic hepatic tumors; there have been also several reports 
evaluating the changes in ALP and HPI in malignant hepatic tumors 
when using PCT [6, 7, 9]. There is also a recent report evaluating ALP 
as a prognostic factor after trans-arterial radio-embolization for hepatic 
metastases of colorectal cancer [14]. 
After the first report described by Blomley et al [12], the maximum 
slope model has been widely used for calculating the ALP, PVP, and 
HPI values from the PCT data set [1, 8, 11, 12]. Using the maximum 
slope model, ALP was determined by dividing the peak gradient of the 
liver time-attenuation curve before the peak splenic enhancement by 
the peak aortic enhancement, and PVP was calculated by dividing the 
peak gradient of the liver time-attenuation curve adjusted by scaled 
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splenic time enhancement after peak splenic attenuation by the peak 
portal trunk enhancement [8, 12]. Considering this theoretical 
background, there are important acquisition points, such as peak aortic 
enhancement, peak splenic enhancement, and peak portal enhancement 
timing, to obtain the ALP, PVP, and HPI value using the maximum 
slope model. I hypothesized that multiphasic dynamic CT scans 
including important time points such as arterial phases containing 
information regarding peak aortic or splenic enhancement and the 
portal venous phase providing peak portal enhancement, could be used 
to obtain the hepatic perfusion parameters including ALP, PVP, and 
HPI. Therefore, the purpose of this study is to investigate the feasibility 
of multiphasic dynamic CT for evaluation of liver tissue perfusion 
characteristics using the maximum slope model in rabbits and in 
humans, compared with perfusion CT (PCT) used as the standard of 
reference.  
 
MATERIALS AND METHODS 
 
Animal Model and Perfusion CT Examination 
Our institutional animal care and use committee approved this 
animal study.  
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Animal model – I used 12, adult, New Zealand white rabbits, each 
weighing 3.0-3.5kg. A heated, circulating water blanket was used to 
maintain the rabbits’ body temperature between 38.5°C and 39.5°C. 
Among the 12 adult rabbits, a VX2 carcinoma strain was maintained in 
six rabbits by successive transplants of tumor cells into the hind limbs 
of the carrier rabbits. I selected VX2 liver carcinoma for the following 
reasons: a) its blood supply is similar to that of human hepatocellular 
carcinoma (HCC); and b) it grows rapidly and to a relatively large size 
that is easily identified on CT images [15, 16]. After induction of 
anesthesia with IV ketamine hydrochloride 50 mg/Kg body weight 
(Ketamine, Yuhan) and 0.1 mL/Kg 2% xylazine (Rompun, Bayer 
Schering Pharma), a midline abdominal incision was made, and the left 
lobe of the rabbit’s liver was exposed. A 20-gauge scalpel (Medicut, 
Ethicon) was used to make a tunnel approximately 0.5-1.0 cm long in 
the anterior subcapsular area of the left medial lobe. A 1-mm3 portion 
of minced, fresh, VX2 carcinoma tissue was locally implanted through 
the tunnel using an ophthalmic nipper. After implantation, the incision 
was closed by gentle pressure using a cotton swab. This method 
promoted growth of a solitary, well-demarcated liver tumor in each 
recipient rabbit [16]. Three weeks after tumor implantation when the 
tumors were expected to be round and to have a 15- to 30-mm diameter, 
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PCT was performed.  
One of the 12 rabbits without a VX2 tumor failed to inject 
contrast-media into the auricular vein due to extravasation during the 
PCT examination. Therefore, functional PCT scan was performed on 
the other 11 rabbits. Among the six rabbits with VX2 tumor 
implantation, one rabbit had one, main liver tumor with three, small, 
daughter nodules, and the other five rabbits had one liver tumor each. 
Each main tumor was included in the analysis, and the daughter 
nodules were excluded. The maximum diameter of all six VX tumors, 
as seen on axial contrast-enhanced CT scans, ranged from 1.0 to 2.8 cm 
(mean 1.7 ± 0.6cm). 
Acquisition of perfusion CT scan - All functional PCT scanning for the 
rabbits was performed with an MDCT unit (Somatom Definition, 
Siemens Medical Solution, Erlangen, Germany). Before the CT scan, 
anesthesia was induced using an intramuscular injection of ketamine 
hydrochloride (50 mg/Kg body weight). After anesthesia, the rabbits 
were fixed on a board in a supine position, and an abdominal bandage 
was tightly applied to so as minimize motion-related artifacts. A 24-
gauge scalpel (Medicut, Ethicon) was then inserted into the rabbit’s 
auricular vein.  
To determine the location of the liver and spleen, an unenhanced 
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CT scan was performed from the diaphragmatic dome to the pelvis 
using the following parameters: detector configuration, 64 x 0.6mm; 
rotation time, 0.5 second; pitch, 0.9; 200mAs; 120kVp; slice 
thickness/reconstruction interval, 1.5mm/1.5mm; and matrix, 512x512. 
According to the location of the liver and spleen, the scan range for 
PCT was selected as 11.4 cm. For functional perfusion imaging, cine 
CT was performed beginning three seconds prior to IV bolus injection 
of contrast material (iopromide, Ultravist 370, Bayer Schering Pharma) 
and continuing for 60 seconds. As one scanning of the whole rabbit 
liver took the 1.5 seconds, a total number of 40 phases was obtained for 
each rabbit. The contrast material was injected through the rabbit 
auricular vein using a power injector (Medrad, Pittsburgh, PA, USA) at 
a rate of 1 mL/s for four seconds [16, 17].  
The PCT imaging scanning parameters were as follows: 80 kVp; 
effective tube current-exposure time product, 100 mAs; rotation time, 
0.33 second; a cycle time, 1.5 seconds; detector configuration, 24 x 1.2 
mm; and field of view, 12 cm2. The CT scans were reconstructed with 
the following parameters: slice thickness, 1 mm; no gap; matrix size, 
512 x 512; scan range, 11.4cm; and total image number, 4560.      
 
Patient Selection and Perfusion CT Examination 
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In the present study, I retrospectively analyzed a prospectively 
collected perfusion CT data of a prospective clinical trial. The phase IV 
clinical trial was registered at http://www.clinicaltrials.gov (study 
number: ISO44-013) for pretherapeutical CT perfusion assessment of 
hepatocellular carcinoma using Xenetix.  
From July 2012 to July 2013, 26 consecutive patients underwent 
perfusion CT for pretherapeutic assessment of hepatocellar carcinoma. 
Among these patients, three were excluded from the PCT analysis for 
the following reasons: greater than 10-cm HCC involving the entire 
right lobe of the liver (n=2); time-enhancement curve showing two–
peak aortic enhancement timing following contrast injection (n=1). 
Finally, 23 patients (M:F=20:3, mean age; 56.8 ± 12.0) were included in 
this study, and we evaluated this PCT data retrospectively. The 
Institutional Review Board of our medical institution approved this 
retrospective study, and written, informed consent had been obtained 
from all included patients.  
Acquisition of perfusion CT scan - Initially, a non-contrast scan 
was obtained through the entire liver. After that, 50ml of nonionic 
contrast material (370 mg I/ml, Xenetix 370; Guerbet) was injected at a 
flow rate of 5ml/sec through an 18-gauge catheter which had been 
placed into the antecubital vein. 50 ml of normal saline flush injected at 
８ 
 
the same rate then followed. Scans started five seconds after injection 
of the contrast material, and which ensured 40 seconds of scans with 
contrast and the first five seconds without contrast. The scan duration 
was 21 stacks with a cycle time of 1.5 seconds. After the 21 stacks of 
continuous scanning, five additional scans with a 1.5-second scan 
duration each and a 1.5-second inter-scan delay, were obtained. The 
scan coverage was selected as 10 cm. The scanning parameters for 
perfusion CT were as follows: detector collimation of 64 x 0.625mm; 
and a gantry rotation time of 0.5 second. The effective tube current was 
200mAs at 80kVp for slim patients (BMI<21), 100mAs at 100kVp for 
normal-sized patients (BMI;21-28), and 150mAs at 100kVp for patients 
whose BMI was greater than 28. All images were reconstructed with 2-
mm thickness at 2-mm increments. In term of the radiation dose for the 
triple arterial phase acquisition protocol used in this study, the mean 
effective radiation dose ranged from 14.0 to 22.0 mSv (mean: 16.7 
mSv). 
 
Analysis of the Perfusion Parameters  
The reconstructed image data were transferred to an imaging 
workstation (Leonardo; Siemens Medical Solutions) for analysis using 
perfusion CT software (VPCT body, Siemens Medical Solutions, 
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Erlangen, Germany) based on the maximum slope model. Before the 
perfusion analysis processes, motion correction was applied for both 
each rabbit and each patient. As the liver moves in a complicated 
fashion during breathing, non-rigid warping techniques are required for 
registration [18], and the VPCT software program used in this study has 
a dedicated, high-performance algorithm. Pixels within the range of -50 
to 150HU values were selected to exclude bone, air, and contrast-
material densities. The aorta was chosen as the input artery and the 
portal vein as the venous input. Spleen parenchyma was also selected to 
determine timing of peak splenic enhancement, which is very important 
for dividing arterial and portal blood flow to the liver according to the 
maximum slope model. I drew regions of interest (ROIs) on the aorta, 
portal vein, and spleen parenchyma in a representative, transverse plane 
(Figure 1a), after which we obtained the time-enhancement curves 
(Figure 1b). 
To quantify the perfusion parameters, I placed ROIs on both the 
representative liver parenchyma (Figure 1c) and the VX2 carcinomas 
(Figure 1d). For the analysis of VX2 carcinoma, the ROIs were drawn 
by outlining the viable tumor portion, as depicted by strong 
enhancement at the tumor periphery. The parametric perfusion maps of 
the arterial liver perfusion (ALP) (ml 100ml-1 min-1), portal venous 
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liver perfusion (PVP) (ml 100ml-1 min-1), and the hepatic perfusion 
index (HPI, %) which is the ratio of the hepatic arterial perfusion to the 
total perfusion, were generated using a high-spatial-resolution, pixel-
by-pixel calculation technique, and the values of the ROIs I had placed 
were automatically calculated (Figure 1c and Figure 1d).  
 
Determining the Number of Phases Required for Calculating 
Perfusion Parameters Using Multiphasic Dynamic CT in an Animal 
Model 
On the basis of the time-enhancement curves, I extracted the 
required phases containing crucial information such as the peak aortic 
or splenic enhancement, from the PCT data set used for calculating the 
perfusion parameters including ALP, PVP, and HPI. According to the 
time-enhancement curve, the following contrast enhancement 
information was obtained: the proximal abdominal aorta had reached 
100 HU approximately three seconds after beginning the contrast 
injection; the peak aortic enhancement achieved approximately six 
seconds after the proximal abdominal aorta had reached 100 HU; and 
the peak spleen parenchymal enhancement was seen approximately six 
seconds after the peak aortic enhancement. To select the phases 
required in order to obtain ALP, PVP, and HPI, I simulated the bolus-
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tracking method which is currently used in many medical institutions 
for multiphasic, contrast-enhanced CT. As the aorta reached its peak 
enhancement six second after triggering, i.e. the proximal abdominal 
aorta had reached 100 HU, I considered this arterial phase as the 
reference arterial phase. To determine the minimum number of phases 
of multiphasic dynamic CT scanning required to calculate ALP, PVP, 
and HPI, I used two different methods. First, I selected seven phases, 
including unenhanced, five arterial and the portal-venous phase. The 
five arterial phases consisted of two more phases earlier and later than 
the reference arterial phase and with a three-second interval. Therefore, 
five arterial phases included the phase obtained after just 100 HU of the 
abdominal aortic enhancement timing, and three, six, 9, and 12 seconds 
after triggering. The portal venous phase was defined as 25 seconds 
after enhancement in the aorta reached 100 HU, as it then showed 
maximum hepatic parenchymal enhancement [16]. Second, I selected 
five phases, including unenhanced, triple arterial, and the portal-venous 
phase. Triple arterial phases consisted of an additional phase earlier and 
later than the reference arterial phase. We used a six-second interval 
rather than a three-second interval in our selection of the triple arterial 
phases as peak splenic enhancement timing was obtained six seconds 
after peak aortic enhancement. Therefore, selected triple arterial phases 
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included the phase obtained after just 100 HU of abdominal aortic 
enhancement timing, and six and 12 seconds after triggering. I 
hypothesized that seven-phase image data sets were closer to the results 
of PCT when compared with five-phase images data sets because more 
contrast-enhancement information was included in seven-phase images.  
The selected phase CT images were transferred to a workstation 
(Leonardo; Siemens Medical Solutions) equipped with commercially 
available software (VPCT body, Siemens Medical Solutions). After 
motion correction using non-rigid warping techniques implemented 
using VPCT body software, the ROIs were placed on the aorta, portal 
vein, and spleen parenchyma in a representative transverse plane, and 
the time-enhancement curves were obtained in a similar manner to that 
used for functional PCT analysis (Figure 2). To obtain the perfusion 
parameters, I placed ROIs on the representative liver parenchyma and 
the viable portion of the VX2 carcinomas in a similar manner to that 
used in functional PCT analysis. The parametric perfusion maps of ALP, 
PVP, and HPI using a high-spatial-resolution, pixel-by-pixel calculation 
technique and the values of the ROIs placed were automatically 
calculated. 
 
Analysis of the Perfusion Parameters Using Multiphasic Dynamic 
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CT in Patient Liver  
I randomly categorized 23 patients into two groups: the validation 
group (n=10) and the evaluation group (n=13). Use of the five–phase, 
dynamic CT data set for obtaining ALP, PVP, and HPI were verified in 
the validation group patients as the animal model showed that the five-
phase image data set could provide the ALP, PVP, and HPI values. 
According to the time-enhancement curve obtained in the validation 
group, the following contrast-enhancement information was obtained: 
the peak aortic enhancement achieved approximately nine seconds after 
the proximal abdominal aorta had reached 100 HU, and the peak spleen 
enhancement was seen approximately nine seconds following peak 
aortic enhancement, i.e. 18 seconds after triggering. Peak portal vein 
enhancement was seen approximately nine seconds following peak 
splenic enhancement, i.e. 27 seconds after triggering  
For obtaining perfusion parameters, including ALP, PVP, and HPI, 
we used the five-phase dynamic CT data set including unenhanced, 
triple arterial, and the portal venous phase. As peak splenic 
enhancement was achieved approximately nine seconds after peak 
aortic enhancement, we used a nine-second interval for the selection of 
triple arterial-phase images. Therefore, selected triple arterial phases 
included the phase obtained with just 100 HU of abdominal aortic 
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enhancement timing, nine and 18 seconds after triggering. The portal 
venous phase was selected as 50 seconds after enhancement when the 
aorta reached 100 HU. The selected phase CT images were then 
transferred to a workstation (Leonardo; Siemens Medical Solutions), 
and perfusion analysis processes were performed using commercially 
available software (VPCT body, Siemens Medical Solutions) in a 
similar manner to that of the rabbit analysis described above. We also 
evaluated the six-phase dynamic CT data set including the five-phase 
dynamic CT data set and the additional phase containing peak portal 
vein enhancement timing in order to determine the significance of the 
peak portal vein enhancement timing for obtaining ALP, PVP, and HPI 
values.  
In the evaluation group patients, the five–phase, dynamic CT data 
set including unenhanced, triple arterial phase images (the phase 
obtained with just 100 HU of abdominal aortic enhancement timing, 
nine and 18 seconds after triggering) and the portal venous phase were 
transferred to a workstation (Leonardo; Siemens Medical Solutions) 
and were then analyzed with perfusion software to obtain the ALP, PVP, 





Perfusion parameters including ALP, PVP, and HPI determined by 
PCT and by selected phases of the dynamic CT scan were compared 
using repeated measures one way analysis of variance (ANOVA). Two-
tailed p < 0.05 was considered as indicating a significant difference. 
When the significant differences were observed, the post hoc, pair-wise 
student t-test with Bonferroni correction was used to determine where 
the significant difference existed.  
To assess the agreement and correlation between the parameters 
obtained by PCT and the parameters obtained by each of the selected 
phases of dynamic CT, the intraclass correlation coefficient (ICC) and 
its two-tailed p-value were also obtained. We considered an ICC value 
of more than 0.81 to represent almost perfect agreement and values of 
0.61–0.80, 0.41–0.60, and 0.21-0.40 to represent substantial, moderate, 
and fair agreement, respectively. A value less than 0.20 was considered 
to represent slight agreement. All statistical analysis was performed 




Perfusion Parameters Obtained Using PCT and Multiphasic 
Dynamic CT in Rabbits 
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Perfusion parameters including ALP, PVP, and HPI determined by 
PCT and by each selected phase dynamic CT data set are summarized 
in Table 1. For PCT, the mean ALP, PVP, and HPI of the liver 
parenchyma were 14.2 ml 100ml-1 min-1, 49.4 ml 100ml-1 min-1, and 
23.0%, respectively. All of the perfusion parameters obtained by the 
seven-phase images data set and by the five phases did not differ 
significantly from that of the functional PCT regarding both the liver 
parenchyma and the viable portion of VX2 carcinoma.  
 
Intraclass Correlation Coefficients of Perfusion Parameters in a 
Rabbit 
The intraclass correlation coefficients between the perfusion 
parameters of PCT and the perfusion parameters obtained from each of 
the selected phases of the dynamic CT are summarized in Table 2. In 
terms of liver parenchyma, the seven-phase images data set and the five 
phases showed statistically significant ICC values and revealed almost 
perfect agreement with PCT regarding all of the perfusion parameters. 
Regarding the viable portion of VX2 carcinoma, the seven-phase 
images data set and the five phases showed substantial to almost perfect 
agreement with PCT regarding ALP, PVP, and HPI. Despite the fact 
that some of the ICC values were not statistically significant, e.g. ICC 
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of PVP (p-value, 0.098) and HPI (p-value, 0.109) for the seven-phase 
images data set, ICC of ALP (p-value, 0.056) for the five-phase images 
data set, the ICC values showed a tendency toward correlation and 
agreement.  
 
Perfusion Parameters Obtained in Patient Liver 
Perfusion parameters obtained using the PCT and multiphasic 
dynamic CT data set, both five- and six-phase, and the ICC values 
between the perfusion parameters with its P-values in the validation 
group, are summarized in Tables 3. All of the perfusion parameters 
obtained using the five- and-six phase dynamic CT data set did not 
differ significantly from that of the PCT. Regarding ICCs between the 
PCT and the multiphasic dynamic CT data set, substantial to almost 
perfect agreement was seen for all perfusion parameters and these ICCs 
were also statistically significant in validation groups of patients. 
Therefore, in the evaluation group, only the five-phase dynamic CT 
data set and the full PCT data set were compared, and the results are 
summarized in Table 4. All perfusion parameters obtained from both 
the five-phase dynamic CT data set and the PCT did not differ 
significantly, and almost perfect agreement was seen between the five-





In this study, multiphasic dynamic CT scans, including important 
time points, could provide ALP, PVP, and HPI values with the use of 
the maximum slope model. ALP, PVP, and HPI values can be obtained 
from both the seven- and the five-phase dynamic CT data sets in rabbit 
liver, and these values did not differ significantly from those of PCT. 
Indeed, substantial to almost perfect agreements with PCT were seen 
for both the seven- and the five-phase images data set.  
For assessing liver parenchyma, none of the perfusion parameters 
obtained by either the seven-phase dynamic CT data set or five-phase 
images differed significantly from that of functional PCT. Furthermore, 
in terms of the correlation and agreement assessed by ICCs, all of the 
perfusion parameters obtained by the seven-phase and five-phase 
dynamic CT data sets significantly agreed with and were correlated 
with that of functional PCT, and the ICC values showed almost perfect 
agreement. In terms of assessing the viable portion of VA2 carcinoma, 
there was no significant difference between the PCT perfusion 
parameters and those of the seven- or five-phase images data sets. For 
agreement of perfusion parameters between the PCT and multi-arterial 
phase data sets, the ICC values of the seven- and five-phase images 
１９ 
 
data sets showed substantial to almost perfect agreement with PCT 
regarding ALP, PVP, and HPI. However, in contrast to the liver 
parenchyma, some ICCs values were not statistically significant, and 
the ICC values tended to be less than those for the liver parenchyma. 
This different finding from that of the normal liver parenchyma could 
be explained by several factors. First, the number of examined tumors 
was much smaller than the number of examined liver parenchyma. As 
six rabbits had VX2 carcinoma in each liver, only six VX2 carcinoma 
nodules could be examined. The small number of examined VX2 
carcinomas might limit the statistical strength of the analysis for the 
assessment of ICCs. Second, the VX2 carcinomas were more 
heterogeneous in nature than normal liver parenchyma. Therefore, 
exact assessment of the perfusion parameters in VX2 carcinoma was 
somewhat more difficult than evaluation of the perfusion parameters in 
normal liver parenchyma.  
In contrast to my expectation, I could not find any significant 
difference between the rabbit perfusion parameters obtained from 
seven- and five-phase dynamic CT data sets regarding any perfusion 
parameters. Therefore, I thought that inclusion of arterial phases which 
contained crucial information such as the peak aortic or splenic 
enhancement timing for estimating the perfusion parameters, was more 
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important than the total number of arterial phases used. I also found 
that the peak portal vein enhancement timing did not have significant 
influence on the estimation of the perfusion parameters, including the 
ALP, PVP, and HPI in the validation group of patients. This result 
might be explained as follows: in contrast to the arterial enhancement, 
portal vein enhancement was sustained for a relatively long time after 
peak enhancement reached, and the decrease in the enhancement degree 
in the portal vein was much slower than that of the artery. Therefore, 
the portal vein enhancement degree might not differ significantly 
between the portal-venous phase and the phase of peak portal vein 
enhancement, i.e. somewhat earlier than the portal-venous phase in this 
study, and thus causing a significant difference in the calculating 
perfusion parameters. Considering these results, it was feasible that 
obtaining the ALP, PVP, and HPI values using the five-phase dynamic 
CT data set, including the triple arterial phase containing the crucial 
information regarding the peak aortic or splenic enhancement and the 
obtained values, did not differ significantly from those obtained from 
the full PCT data set. For the application of the five–phase, dynamic 
CT data set in order to obtain the ALP, PVP, and HPI in patient liver, 
detailed contrast-enhancement characteristics of human beings, 
including information regarding how long it took to reach the peak 
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aortic and splenic enhancement after triggering, i.e. enhancement in the 
proximal abdominal aorta reached 100 HU, should be defined. In our 
preliminary results, peak aortic enhancement was seen approximately 
nine seconds after enhancement in the proximal abdominal aorta 
reached 100HU, and peak splenic enhancement was achieved 
approximately 18 seconds after triggering in the validation group. 
Given that peak splenic enhancement was usually seen in the late-
arterial phase and previously established late arterial-phase images 
could be obtained 17 to 18 seconds after triggering, our patient results 
in the validation group corroborate these findings. I also analyzed the 
evaluation group and obtained the ALP, PVP, and HPI values using the 
five–phase, dynamic CT data set with the information regarding 
contrast kinetics regarding peak aortic and splenic enhancement from 
the validation group. In the evaluation group of patients, the values of 
the ALP, PVP, and HPI obtained from the five-phase dynamic CT data 
set, did not differ significantly from that of the full PCT data set and 
also showed almost perfect agreement with the PCT results. 
Considering these results, it was feasible to obtain the ALP, PVP, and 
HPI values from the five–phase, dynamic CT data set, including the 
triple-arterial phases containing crucial enhancement information. 
However, this study results should be verified in a large series study. 
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Regarding the exposed radiation dose, the five–phase, dynamic CT 
data set clearly required less radiation than the full PCT data set. As the 
PCT protocol used in this study included a total number of 40 phase 
images for rabbits and included 36 phases for patients, theoretically, 
approximately one-eighth of the radiation dose was needed for the five-
phase dynamic CT data set compared with the full PCT data set. 
Therefore, this study result suggests the possibility of extending the 
clinical application of perfusion imaging and decreasing the radiation 
dose for obtaining the perfusion parameters. To reduce the radiation 
dose in five-phase dynamic CT acquisition for estimating the ALP, PVP, 
and HPI, an iterative reconstruction algorithm can also be used [19, 20]. 
With the technical development of MDCT, such as wider detector 
coverage, five–phase, dynamic CT scanning can also cover the entire 
liver, thus making simultaneous assessment of the morphologic and 
functional evaluation possible. All of these technical developments 
might expand the role of CT to functional imaging. Information 
regarding hemodynamic changes in malignant tumor or liver 
parenchyma may provide crucial information for clinical practice. For 
example, perfusion parameters can predict the tumor response in the 
treatment of pancreatic or rectal cancer [21, 22]. Recently, Morsbach et 
al. reported that the ALP of metastatic colon cancer in liver could be 
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used as a prognostic factor after trans-arterial radio-embolization [14]. 
Perfusion imaging can also be used to predict tumor response to 
antiangiogenic drug therapy [23]. This study results might suggest the 
possibility of clinical application of perfusion imaging as it decreases 
the radiation dose and increases scanning coverage.  
This study had several limitations which should be mentioned. 
First, the number of rabbits and patients included in this study was 
relatively small, and the animal sample was uniform i.e. clonal VX2 
carcinomas in otherwise healthy, similar-sized rabbits without any 
hepatic or cardiovascular diseases and which could alter the hepatic 
hemodynamic. Therefore, the study design might be optimistic rather 
than useful in actual clinical practice. Second, I extracted needed 
phases for obtaining the ALP, PVP, and HPI from the PCT data set, and 
the rescanning according to the multiphasic dynamic CT acquisition 
protocol defined by our study result was not performed and might also 
have resulted in optimistic study results. The duration, volume, and 
concentration of contrast injection between the multiphasic dynamic 
liver CT and PCT can differ and this difference can alter the perfusion 
parameter analysis. Third, the calculated perfusion parameters in the 
maximum slope model also depend on the bolus volume, rate of 
injection, and cardiac output, and we did not assess the influence of 
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these parameters on the calculated ALP, PVP, and HPI. Noise level in 
the images also affects the calculated perfusion parameters and must be 
minimized in order to achieve the optimal outcome. We also did not 
assess the influence of the noise level on the estimated ALP, PVP, and 
HPI values. Fourth, VX2 carcinoma is a metastatic hepatic tumor 
model with prominent neoangiogenesis, and which differs from HCC in 
that an HCC shows capillary formation in sinusoidal endothelium with 
neoplastic transformation. Thus, the application of our study results 
may be somewhat limited to the evaluation of liver metastasis.  
In conclusion, obtaining perfusion parameters using a multiphasic 
dynamic CT scan data set was feasible, and five phases including 
crucial contrast enhancement information might be sufficient for 
calculating the ALP, PVP and HPI values. In addition, the perfusion 
parameters of the liver and the VX2 tumors using the dynamic CT 




Table 1. Perfusion parameters determined by PCT as well as by 












(mean ± SD) 
14.2 ± 3.6 15.4 ± 3.7 16.0 ± 4.4 0.132 
PVP  
(mean ± SD) 
49.4 ± 12.2 51.7 ± 14.5 53.9 ± 16.1 0.376 
HPI  
(mean ± SD) 




(mean ± SD) 
29.5 ± 3.8 29.7 ± 6.0 26.5 ± 4.4 0.867 
PVP  
(mean ± SD) 
4.6 ± 2.1 5.9 ± 1.8 4.4 ± 1.9 0.149 
HPI  
(mean ± SD) 
87.0 ± 2.6 86.6 ± 3.5 87.8 ± 4.3 0.753 
 
*, the p-value was determined by repeated measures one-way analysis 
of variance.  
ALP, arterial liver perfusion (ml 100ml-1 min-1) 
PVP, portal venous liver perfusion (ml 100ml-1 min-1) 
HPI, hepatic perfusion index (%) 
CT, computed tomography 


















Table 2. Intraclass correlation coefficients between the perfusion 
parameters of PCT and those of both the seven- and five-phase 
dynamic CT data set 
 




ALP [ ICCs (p-value)] 0.855 (0.002) 0.856 (0.001) 
PVP [ ICCs (p-value)] 0.894 (0.001) 0.911 ( < 0.001) 
HPI [ ICCs (p-value)] 0.855 (0.002) 0.854 (0.003) 
Tumor 
(n=6) 
ALP [ ICCs (p-value)] 0.909 (0.014) 0.701 (0.056) 
PVP [ ICCs (p-value)] 0.654 (0.098) 0.723 (0.024) 
HPI [ ICCs (p-value)] 0.729 (0.109) 0.670 (0.044) 
 
PCT, functional perfusion computed tomography 
ICC, intraclass correlation coefficient 
ALP, arterial liver perfusion 
PVP, portal venous liver perfusion 



























Table 3. Perfusion parameters determined by PCT and the 











PCT vs 5P 
ICC (p-
value) 






































*, p-value was determined by repeated measures one-way analysis of 
variance.  
PCT, functional perfusion computed tomography 
ICC, intraclass correlation coefficient 
ALP, arterial liver perfusion (ml 100ml-1 min-1) 
PVP, portal venous liver perfusion (ml 100ml-1 min-1) 
HPI, hepatic perfusion index (%) 





















Table 4. Perfusion parameters determined by PCT and by the five-
phase dynamic CT data set in the patient evaluation group 
 
 PCT Five phases P-value* ICC (p-value) 
ALP 9.77 ± 1.83 10.18 ± 1.84 0.227 0.806 (<0.001) 
PVP 27.51 ± 5.02 29.10 ± 4.40 0.139 0.772 (<0.001) 
HPI 26.40 ± 4.38 26.09 ± 3.97 0.362 0.959 (<0.001) 
 
*, p-value was determined by paired t-test 
PCT, functional perfusion computed tomography 
ICC, intraclass correlation coefficient 
ALP, arterial liver perfusion (ml 100ml-1 min-1) 
PVP, portal venous liver perfusion (ml 100ml-1 min-1) 
HPI, hepatic perfusion index (%) 


























Figure 1. PCT analysis. 
*PCT: perfusion CT 
 (a) Contrast enhanced transverse CT images of rabbit shows 
placement of regions of interest (ROIs); left (aorta), middle (portal 


















 (b) Time-enhancement curves of the selective ROIs obtained from 
functional perfusion CT data. A represents scan start and B, C, D and E 
represent start of contrast injection, proximal abdominal aorta reached 
100 HU (triggering point in bolus tracking method), peak aortic 























 (c) The ROIs was placed on rabbit liver parenchyma, and the 
parametric perfusion maps with a high-spatial-resolution pixel-by-pixel 



















Arterial liver perfusion 
Portal venous perfusion Hepatic perfusion index 
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 (d) The ROIs was placed on viable portion of VX2 carcinoma, and the 





















Portal venous Hepatic perfusion 
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Figure 2. Time-enhancement curves obtained by seven and five phase 
dynamic CT data set; 











(b) five phase dynamic CT data set. A represents scan start and B, C, D 
and E represent start of contrast injection, proximal abdominal aorta 
reached 100 HU (triggering point in bolus tracking method), peak 
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목적: 다중시기 전산화 단층 촬영과 최대 기울기 모형을 
이용하여 간 관류 정보 획득의 실행 가능성을 토끼를 이용한 
동물 모델과 환자군 에서 관류 전산화 단층 촬영의 결과를 
표준으로 이용하여 평가한다. 
방법: 관류 전산화 단층 촬영을 11마리의 토끼에서 
시행하였으며 이중 6마리의 토끼는 VX2 종양을 가지고 
있었다. 다중시기 전산화 단층 촬영을 이용하여 관류 정보 
획득 가능성을 평가하기 위하여 토끼를 이용한 동물 모델에서 
두 가지 다른 영상 데이터 집합을 관류 전산화 단층 촬영 
데이터 집합에서 선택하였다: 첫 번째, 다섯 시기 동맥기 
영상을 포함한 일곱 시기 영상 데이터 집합; 두 번째, 최대 
대동맥 조영 시기와 최대 비장 조영 시기의 정보를 가지고 
있는 삼중 동맥기 영상을 포함한 다섯 시기 영상 데이터 집합. 
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환자군 연구에서는 만성 간질환을 가진 23명의 환자에서 관류 
전산화 단층 촬영을 시행하였다. 이중 10명의 환자는 토끼를 
이용한 동물 모델에서의 결과를 확인하기 위한 입증군으로, 
13명의 환자는 평가군으로 나누었다. 삼중 동맥기 영상, 
비조영 영상, 간문맥기 영상을 포함한 다섯 시기 영상 데이터 
집합이 최대 기울기 모형을 이용한 관류 정보 획득에 
이용되었다. 선택된 각각의 다중 시기 전산화 단층 촬영 영상 
데이터의 집합과 관류 전산화 단층 촬영의 데이터 집합은 
VPCT body라는 관류 영상 소프트웨어를 이용하여 분석하였다. 
각 데이터 집합에서 얻어진 관류 정보 값들 사이의 비교와 
일치도를 평가하기 위하여 반복 측정 분산 분석과 급내 상관 
계수를 이용하였다. 
결과: 토끼를 이용한 동물 모델에서 간 실질과 VX2 종양에 
대해 얻어진 관류 정보 값들은 관류 전산화 단층 촬영 
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데이터를 이용하거나 일곱 시기 혹은 다섯 시기 전산화 단층 
촬영 데이터 집합을 이용하였을 때 모두 유의하게 다르지 
않았으며, 0.6 이상의 급내 상관 계수가 얻어져 상당한 정도의 
일치도를 보였다. 또한, 환자군 연구에서 간 실질에 대해 
얻어진 관류 정보의 값들은 관류 전산화 단층 촬영 데이터를 
이용하거나 다섯 시기 전산화 단층 촬영 데이터 집합을 
이용하였을 때 모두 유의하게 다르지 않았으며, 급내 상관 
계수 0.8 이상의 높은 일치도를 보였다. 
결론: 다중 시기 전산화 단층 촬영과 최대 기울기 모형을 
이용하여 간 관류 정보 값의 획득은 가능하며, 이렇게 다중 
시기 전산화 단층 촬영을 이용하여 얻어진 관류 정보 값은 
관류 전산화 단층 촬영을 이용하여 얻은 관류 정보 값과 
유사하며 높은 일치도를 보인다. 
 
